ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Arena Announces First Subject Dosed Etrasimod Trial for Ulcerative Colitis americanpharmaceuticalreview
September 23, 2020Arena Pharmaceuticals announced the first subject has been dosed in the ELEVATE UC 12 global Phase 3 trial evaluating etrasimod, an investigational, next-generation, once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator ...
Pharma Sources Insight January 2025
